Your browser doesn't support javascript.
loading
In vitro and in vivo activity of a novel locked nucleic acid (LNA)-inhibitor-miR-221 against multiple myeloma cells.
Di Martino, Maria Teresa; Gullà, Annamaria; Gallo Cantafio, Maria Eugenia; Altomare, Emanuela; Amodio, Nicola; Leone, Emanuela; Morelli, Eugenio; Lio, Santo Giovanni; Caracciolo, Daniele; Rossi, Marco; Frandsen, Niels M; Tagliaferri, Pierosandro; Tassone, Pierfrancesco.
Afiliação
  • Di Martino MT; Department of Experimental and Clinical Medicine, Magna Graecia University and Medical Oncology Unit, Salvatore Venuta University Campus, Catanzaro, Italy ; T. Campanella Cancer Center, Salvatore Venuta University Campus, Catanzaro, Italy.
  • Gullà A; Department of Experimental and Clinical Medicine, Magna Graecia University and Medical Oncology Unit, Salvatore Venuta University Campus, Catanzaro, Italy.
  • Gallo Cantafio ME; Department of Experimental and Clinical Medicine, Magna Graecia University and Medical Oncology Unit, Salvatore Venuta University Campus, Catanzaro, Italy.
  • Altomare E; Department of Experimental and Clinical Medicine, Magna Graecia University and Medical Oncology Unit, Salvatore Venuta University Campus, Catanzaro, Italy.
  • Amodio N; Department of Experimental and Clinical Medicine, Magna Graecia University and Medical Oncology Unit, Salvatore Venuta University Campus, Catanzaro, Italy.
  • Leone E; Department of Experimental and Clinical Medicine, Magna Graecia University and Medical Oncology Unit, Salvatore Venuta University Campus, Catanzaro, Italy.
  • Morelli E; Department of Experimental and Clinical Medicine, Magna Graecia University and Medical Oncology Unit, Salvatore Venuta University Campus, Catanzaro, Italy.
  • Lio SG; Pathology Unit, "Giovanni Paolo II" Hospital, Lamezia Terme, Catanzaro, Italy.
  • Caracciolo D; Department of Experimental and Clinical Medicine, Magna Graecia University and Medical Oncology Unit, Salvatore Venuta University Campus, Catanzaro, Italy.
  • Rossi M; Department of Experimental and Clinical Medicine, Magna Graecia University and Medical Oncology Unit, Salvatore Venuta University Campus, Catanzaro, Italy ; T. Campanella Cancer Center, Salvatore Venuta University Campus, Catanzaro, Italy.
  • Frandsen NM; Exiqon A/S, Vedbaek, Denmark.
  • Tagliaferri P; Department of Experimental and Clinical Medicine, Magna Graecia University and Medical Oncology Unit, Salvatore Venuta University Campus, Catanzaro, Italy ; T. Campanella Cancer Center, Salvatore Venuta University Campus, Catanzaro, Italy.
  • Tassone P; Department of Experimental and Clinical Medicine, Magna Graecia University and Medical Oncology Unit, Salvatore Venuta University Campus, Catanzaro, Italy ; T. Campanella Cancer Center, Salvatore Venuta University Campus, Catanzaro, Italy ; Sbarro Institute for Cancer Research and Molecular Medicine
PLoS One ; 9(2): e89659, 2014.
Article em En | MEDLINE | ID: mdl-24586944
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: MicroRNAs / Mieloma Múltiplo / Antineoplásicos Idioma: En Ano de publicação: 2014 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: MicroRNAs / Mieloma Múltiplo / Antineoplásicos Idioma: En Ano de publicação: 2014 Tipo de documento: Article